This inventor holds 1 USPTO granted patent. Top assignee: Ames-Yissum Ltd.. Active years: 1982.
Company Filing History:
Years Active: 1982
Title: **Innovative Contributions of Zohar Ben-Moyal in Assay Technology**
Introduction
Zohar Ben-Moyal, an esteemed inventor based in Jerusalem, Israel, has made significant strides in the field of assay technology. With one patent to his name, he has advanced methodologies that facilitate the simultaneous determination of various ligands in a single liquid test sample. His work exemplifies the intersection of innovation and practical application in the biomedical field.
Latest Patents
Zohar Ben-Moyal holds a patent for a "Combined heterogeneous specific binding assay." This innovative assay method allows for the simultaneous detection of multiple ligands, such as antibodies, antigens, or haptens, within a single sample. The assay employs solid-phase binding agents that are differentially separable, enabling the use of a single label for various ligands, which enhances efficiency in laboratory settings. This technology is particularly beneficial for identifying different antibodies against viral antigens in serum samples.
Career Highlights
Ben-Moyal's career is marked by a commitment to advancing testing methodologies that improve diagnostic accuracy. Working at Ames-Yissum Ltd., he has become an essential figure in the development of innovative assays that contribute to biomedical research and healthcare. His patent reflects a deep understanding of both the scientific and practical aspects of assay design, making him a valuable asset to his team.
Collaborations
Throughout his professional journey, Zohar has collaborated with notable colleagues, including Bertold R. Fridlender and Udi Olshevsky. These partnerships emphasize the importance of teamwork in bringing innovative ideas to life, showcasing how collaborative efforts can lead to groundbreaking advancements in technology.
Conclusion
Zohar Ben-Moyal is a prominent inventor whose work has significantly impacted assay technology. His patent for a combined heterogeneous specific binding assay exemplifies the importance of innovation in improving laboratory practices and diagnostic procedures. Through his career at Ames-Yissum Ltd. and collaborations with skilled colleagues, Ben-Moyal continues to pave the way for future advancements in the biomedical field.